Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of L-citrulline in Infants with BPD at Risk of Pulmonary Hypertension
NCT03542812Phase 1Terminated
- Sponsor
- University of Utah
- Start
- Jul 2019
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of citrulline in pulmonary hypertension (PH) (2 arms), sponsored by University of Utah. Primary endpoints: Plasma L-citrulline Levels Following Administration, Number of Participants With Feedings Being Stopped Following L-citrulline Administration and 1 more. Started Jul 2019; status: terminated.
02
Drugs
citrulline
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03542812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542812.